$BTMD News
Last published 1w ago
- 1w agoBTMDThird Quarter 2026 Earnings Conference Call - BIOTE CORPEarnings Call TranscriptsWelcome to the BioTee 3rd Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.
- 1w agoBTMDThird Quarter 2026 Earnings Conference Call - BIOTE CORPEarnings Call TranscriptsWelcome to the BioTee 3rd Quarter 2026 Earnings Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero.
- 1w agoBTMDbiote Corp. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 3w agoBTMDBiote Schedules Third Quarter 2026 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today announced
- 3mo agoBTMDSecond Quarter 2026 Earnings Conference Call - BIOTE CORPEarnings Call TranscriptsThank you for standing by. My name is Tina, and I will be your conference operator. At this time, I would like to welcome everyone to the Biotese Second Quarter 2026 Earnings Conference Call. All lines have been placed o
- 3mo agoTMDBTMDBiote Reports Second Quarter 2026 Financial ResultsBusiness WireContinued progress in advancing strategic initiatives Updates full-year outlook Second Quarter 2026 Financial Highlights Revenue of $44.2 million Gross profit margin of 65.4% Net loss of $(7.4) million and
- 3mo agoBTMDBiote Schedules Second Quarter 2026 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today announced
- 5mo agoBTMDBiote Appoints Komal Bajaj, MD, MS as Chief Medical OfficerBusiness WireBiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company") today announced the appointment of Komal Bajaj, MD, MS, as Chief Medical Officer, effective June 1, 2026. Dr. Bajaj is a nationally recognized physician executive,
- 5mo agoBTMDBiote Names Bob Peterson, Current Chief Financial and Chief Business Officer, as Interim CEOBusiness WireBret Christensen Stepping Down as CEO for Family and Personal Reasons, Remains a Director Company Reaffirms Full Year 2026 Guidance Biote (NASDAQ:BTMD), a leader in innovative hormone optimization and healthy aging
- 6mo agoBTMDBiote Reports First Quarter 2026 Financial ResultsBusiness WireSales team expansion on track and nearing targeted level Return to procedure growth expected in second half of 2026 First Quarter 2026 Financial Highlights Revenue of $44.9 million Gross profit margin of
- 6mo agoBTMDBiote Schedules First Quarter 2026 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners' patients, today announced the Company will
- 8mo agoBTMDBiote Reports Fourth Quarter and Full Year 2025 Financial ResultsBusiness WireExecuting efficiently on strategic priorities Continued salesforce expansion to capture large growth opportunity Anticipate a return to procedure revenue growth in the second half of 2026 Fourth Quarter 2025
- 8mo agoBTMDBiote Schedules Fourth Quarter and Full Year 2025 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading innovator advancing the healthspan of patients' lives by providing hormone replacement therapy and healthy aging solutions, today announced the Company
- 1y agoBTMDBiote Schedules Third Quarter 2025 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 1y agoBTMDbiote Corp. (BTMD) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBTMDBiote Reports Second Quarter 2025 Financial ResultsBusiness WireQ2 financial performance driven by strong dietary supplement sales and gross margin expansion Launched corporate reorganization to increase new clinic and procedure growth Decisive actions position Biote for
- 1y agoBTMDBiote Schedules Second Quarter 2025 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 1y agoBTMDBiote Names Rich Barrera to Board of DirectorsBusiness Wirebiote Corp.(NASDAQ:BTMD), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its Board of Directors has
- 1y agoBTMDBiote Reports First Quarter 2025 Financial ResultsBusiness WireStrong financial performance driven in part by increased gross margin from vertical integration Announces organizational restructuring to drive sustainable growth and build long-term value Maintains 2025 financial
- 1y agoBTMDBiote Schedules First Quarter 2025 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 1y agoBTMDBiote Announces Purchase of Shares by Directors and CEOBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company") a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that
- 1y agoBTMDBiote Reports Fourth Quarter and Full Year 2024 Financial ResultsBusiness WireStrengthened business with launch of BioteRx and enhancements to Biote Method Provides fiscal 2025 outlook Biote (NASDAQ:BTMD), a leading solutions provider in preventive health care through the delivery of
- 1y agoBTMDBiote Schedules Fourth Quarter and Full Year 2024 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 1y agoBTMDHOLXMYGNPODDBiote Announces CEO Retirement and Succession PlanBusiness WireTerry Weber Retiring as CEO and Director and Transitioning to Strategic Advisor to Company's Board of Directors Health Care Veteran Bret Christensen to Succeed Terry Weber as CEO and Director biote Corp.
- 1y agoREXRBTMDAccessHope Expands Executive Leadership Team Amid Rapid Growth and Upcoming Market ExpansionPR NewswireAccessHope, LLC, a company changing the way leading-edge cancer expertise is delivered, today announced that it is expanding its executive leadership ...
- 1y agoBTMDbiote Corp. (BTMD) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBTMDBiote Reports Third Quarter 2024 Financial ResultsBusiness WireContinued Profitable Growth Vertical integration drives gross profit margin improvement Launch of proprietary clinical decision support software to strengthen competitive advantages Biote (NASDAQ:BTMD), a leading
- 2y agoBTMDBiote Schedules Third Quarter 2024 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 2y agoBTMDbiote Corp. (BTMD) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBTMDBiote Reports Second Quarter 2024 Financial ResultsBusiness WireProcedure revenue growth accelerates sequentially BioteRx roll-out on track with further expansion planned Management reiterates 2024 financial guidance Biote (NASDAQ:BTMD), a leading solutions provider in
- 2y agoBTMDBiote Schedules Second Quarter 2024 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 2y agoBTMDBiote Announces $60 Million Agreement to Repurchase 8.3 Million Shares and Cancel Approximately 4.0 Million Earnout SharesBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced it has
- 2y agoBTMDbiote Corp. (BTMD) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoBTMDBiote Reports First Quarter 2024 Financial ResultsBusiness WireProcedure revenue growth and strengthened profitability drive solid financial performance Phased launch of BioteRx remains on track Reaffirms 2024 financial guidance, with an acceleration in second half
- 2y agoBTMDBiote Announces Definitive Settlement with FounderBusiness WireCompany to repurchase all of Founder's 18.4 million shares at $4.17 per share biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of
- 2y agoBTMDBiote Schedules First Quarter 2024 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 2y agoBTMDBiote Reports Fourth Quarter and Full Year 2023 Financial ResultsBusiness WireGrew practitioner network to over 7,100 from 6,400 in 2022 Launched BioteRx, our new hormone and therapeutic wellness offerings Enhancing shareholder value with agreement to repurchase 18.4M founders' shares in
- 2y agoBTMDBiote Schedules Fourth Quarter and Full Year 2023 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced the
- 2y agoBTMDBiote Announces Agreement to Resolve Litigation and Repurchase All of Founder's SharesBusiness WireCompany to repurchase approximately 18.4 million Class A shares and Paired Interests at $4.17 per share biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care
- 2y agoBTMDBiote Announces $20 Million Share Repurchase AuthorizationBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that its
- 2y agoBTMDBiote to Purchase Asteria HealthBusiness WireStrategic and accretive transaction enables vertical integration of hormone product manufacturing biote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through
- 2y agoBTMDBiote Provides Preliminary 2023 Results and Initial 2024 GuidanceBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that
- 2y agoBTMDBiote Names Robert Peterson as Chief Financial OfficerBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone optimization and therapeutic wellness, today announced that
- 3y agoBTMDBiote Reports Third Quarter 2023 Financial ResultsBusiness WireAchieves Progress in Test of Complementary Wellness Therapeutics Reiterates 2023 Financial Guidance Biote (NASDAQ:BTMD), a leading solutions provider in preventive health care through the delivery of personalized
- 3y agoBTMDBiote Schedules Third Quarter 2023 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading provider of hormone optimization, today announced the Company will provide third quarter financial results on Tuesday, November 7, 2023, after the close of
- 3y agoBTMDBiote Schedules Second Quarter 2023 Financial Results Release and Conference CallBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading provider of hormone optimization, today announced the Company will provide second quarter financial results on Thursday, August 10, 2023, after the close
- 3y agoBTMDBiote Formalizes Commitment to Men's Hormone Health With Launch of New Men's Health DivisionBusiness WireLeader in Hormone Education and Training Aims to Increase Awareness and Access to Testosterone Deficiency Therapy through Expanded Network of Urologists and Internal Medicine Practitioners biote Corp. (NASDAQ:BTMD)
- 3y agoBTMDBiote Announces Expiration and Results of Exchange Offer and Consent Solicitation Relating to WarrantsBusiness WireBiote (NASDAQ:BTMD) (the "Company," "we" or "us"), a leading solutions provider in preventive healthcare through the delivery of personalized hormone therapy, today announced the expiration and results of its previously
- 3y agoBTMDBiote Announces Pricing of Secondary Offering of Common StockBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the pricing of an underwritten offering of
- 3y agoBTMDBiote to Participate at Upcoming Investor ConferencesBusiness Wirebiote Corp. (NASDAQ:BTMD) ("Biote" or the "Company"), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced its participation at the following